Search Results
Search for other papers by Riccarda Granata in
Google Scholar
PubMed
Search for other papers by Marco Volante in
Google Scholar
PubMed
Search for other papers by Fabio Settanni in
Google Scholar
PubMed
Search for other papers by Carlotta Gauna in
Google Scholar
PubMed
Search for other papers by Corrado Ghé in
Google Scholar
PubMed
Search for other papers by Marta Annunziata in
Google Scholar
PubMed
Search for other papers by Barbara Deidda in
Google Scholar
PubMed
Search for other papers by Iacopo Gesmundo in
Google Scholar
PubMed
Search for other papers by Thierry Abribat in
Google Scholar
PubMed
Search for other papers by Aart-Jan van der Lely in
Google Scholar
PubMed
Search for other papers by Giampiero Muccioli in
Google Scholar
PubMed
Search for other papers by Ezio Ghigo in
Google Scholar
PubMed
Search for other papers by Mauro Papotti in
Google Scholar
PubMed
Glucose-dependent insulinotropic polypeptide-mediated up-regulation of beta-cell antiapoptotic Bcl-2 gene expression is coordinated by cyclic AMP (cAMP) response element binding protein (CREB) and cAMP-responsive CREB coactivator 2 . Molecular and
Centre of Membrane Proteins and Receptors (COMPARE), Universities of Birmingham and Nottingham, Birmingham, UK
Search for other papers by Aqfan Jamaluddin in
Google Scholar
PubMed
Centre of Membrane Proteins and Receptors (COMPARE), Universities of Birmingham and Nottingham, Birmingham, UK
Search for other papers by Caroline M Gorvin in
Google Scholar
PubMed
Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (also known as gastric inhibitory peptide, GIP) are gut-derived hormones known as incretins, as they promote the secretion of insulin. GLP-1 is processed from the pro
Search for other papers by Özlem Erdogdu in
Google Scholar
PubMed
Search for other papers by Linnéa Eriksson in
Google Scholar
PubMed
Search for other papers by Hua Xu in
Google Scholar
PubMed
Search for other papers by Åke Sjöholm in
Google Scholar
PubMed
Search for other papers by Qimin Zhang in
Google Scholar
PubMed
Search for other papers by Thomas Nyström in
Google Scholar
PubMed
( Tripathy et al . 2003 ). Glucagon-like peptide-1 (GLP1) is a brain gut insulinotropic hormone that plays an important role in the regulation of glucose homeostasis and thus has been applied in clinical treatment of diabetes ( Drucker & Nauck 2006
Search for other papers by Sheng Wu in
Google Scholar
PubMed
Search for other papers by Graeme J Roch in
Google Scholar
PubMed
Search for other papers by Laura A Cervini in
Google Scholar
PubMed
Search for other papers by Jean E Rivier in
Google Scholar
PubMed
Search for other papers by Nancy M Sherwood in
Google Scholar
PubMed
Glucose-dependent insulinotropic polypeptide GIP ++ − ++ GIP Receptor Pituitary adenylate cyclase-activating polypeptide PAC1R ++ + ++ ADCYAP1R1 GH-releasing hormone-like peptide GHRH-LPR a (PRPR a ) ++ + − VIP–PACAP receptor 1 VPAC1R ++ + ++ VIPR1
Search for other papers by Ilitch Aquino Marcondes-de-Castro in
Google Scholar
PubMed
Search for other papers by Thamiris Ferreira Oliveira in
Google Scholar
PubMed
Search for other papers by Renata Spezani in
Google Scholar
PubMed
Search for other papers by Thatiany Souza Marinho in
Google Scholar
PubMed
Search for other papers by Luiz Eduardo Macedo Cardoso in
Google Scholar
PubMed
Search for other papers by Marcia Barbosa Aguila in
Google Scholar
PubMed
Search for other papers by Carlos Alberto Mandarim-de-Lacerda in
Google Scholar
PubMed
. ( https://doi.org/10.1073/pnas.2022120118 ) De Block CEM Dirinck E Verhaegen A Van Gaal LF 2022 Efficacy and safety of high-dose glucagon-like peptide-1, glucagon-like peptide-1/glucose-dependent insulinotropic peptide, and glucagon-like peptide
Search for other papers by Guoqing Lei in
Google Scholar
PubMed
Search for other papers by Linxi Chen in
Google Scholar
PubMed
Search for other papers by Miao Peng in
Google Scholar
PubMed
Search for other papers by Bolin Zeng in
Google Scholar
PubMed
Search for other papers by Qiaoxi Yang in
Google Scholar
PubMed
Search for other papers by Hening Zhai in
Google Scholar
PubMed
Search for other papers by Geyang Xu in
Google Scholar
PubMed
(7-36) amide form, with a lesser amount of the bioactive GLP-1(7-37) form also detectable ( Kreymann et al. 1987 ). The biological activities of GLP-1 include stimulation of glucose-dependent insulin secretion and insulin biosynthesis, inhibition of glucagon
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
COMPARE University of Birmingham and University of Nottingham Midlands, Birmingham, UK
Search for other papers by Daniela Nasteska in
Google Scholar
PubMed
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
COMPARE University of Birmingham and University of Nottingham Midlands, Birmingham, UK
Search for other papers by David J Hodson in
Google Scholar
PubMed
/ion channels. Perhaps the best characterised signals are derived from the incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) released from the enteroendocrine L-cells and K-cells, respectively, following food
Search for other papers by Janice K V Tam in
Google Scholar
PubMed
Search for other papers by Leo T O Lee in
Google Scholar
PubMed
Search for other papers by Jun Jin in
Google Scholar
PubMed
Search for other papers by Billy K C Chow in
Google Scholar
PubMed
histidine isoleucine (PHI)/peptide histidine methionine (PHM), growth hormone-releasing hormone (GHRH), secretin (SCT), glucagon (GCG), glucagon-like peptide 1 (GLP1), glucagon-like peptide 2 (GLP2), and glucose-dependent insulinotropic peptide (or gastric
Search for other papers by James E P Brown in
Google Scholar
PubMed
Search for other papers by David J Onyango in
Google Scholar
PubMed
Search for other papers by Manjunath Ramanjaneya in
Google Scholar
PubMed
Search for other papers by Alex C Conner in
Google Scholar
PubMed
Search for other papers by Snehal T Patel in
Google Scholar
PubMed
Search for other papers by Simon J Dunmore in
Google Scholar
PubMed
Search for other papers by Harpal S Randeva in
Google Scholar
PubMed
.775 Glucagon 1.782 0.652 Glucagon receptor 2.297 0.873 Glucose transporter type 4 2.701 0.624 Glucagon-like peptide 1 receptor 1.072 0.284 Glycerol-3-phosphate dehydrogenase 1 (soluble) 2.962 0.172 Glycogen synthase kinase 3β −1.447 0.266 Heme oxygenase
Laboratory for Molecular Dynamics of Mental Disorders, RIKEN Center for Brain Science, Wako-shi, Saitama, Japan
Search for other papers by Takumi Nakamura in
Google Scholar
PubMed
Search for other papers by Kazuki Harada in
Google Scholar
PubMed
Search for other papers by Taichi Kamiya in
Google Scholar
PubMed
Search for other papers by Mai Takizawa in
Google Scholar
PubMed
Search for other papers by Jim Küppers in
Google Scholar
PubMed
Search for other papers by Kazuo Nakajima in
Google Scholar
PubMed
Search for other papers by Michael Gütschow in
Google Scholar
PubMed
Search for other papers by Tetsuya Kitaguchi in
Google Scholar
PubMed
Search for other papers by Kunihiro Ohta in
Google Scholar
PubMed
Search for other papers by Tadafumi Kato in
Google Scholar
PubMed
Search for other papers by Takashi Tsuboi in
Google Scholar
PubMed
J Rasmussen C Coy DH Holst JJ 2008 Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas . Diabetologia 2263 – 2270